These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 25490331)

  • 1. Methods for evaluating changes in health care policy: the difference-in-differences approach.
    Dimick JB; Ryan AM
    JAMA; 2014 Dec; 312(22):2401-2. PubMed ID: 25490331
    [No Abstract]   [Full Text] [Related]  

  • 2. Health policy analysis: a simple tool for policy makers.
    Collins T
    Public Health; 2005 Mar; 119(3):192-6. PubMed ID: 15661129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health policy and outcomes research 2004.
    Matchar DB; Rudd AG
    Stroke; 2005 Feb; 36(2):225-7. PubMed ID: 15637316
    [No Abstract]   [Full Text] [Related]  

  • 4. Designing Difference in Difference Studies: Best Practices for Public Health Policy Research.
    Wing C; Simon K; Bello-Gomez RA
    Annu Rev Public Health; 2018 Apr; 39():453-469. PubMed ID: 29328877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legislating against use of cost-effectiveness information.
    Neumann PJ; Weinstein MC
    N Engl J Med; 2010 Oct; 363(16):1495-7. PubMed ID: 20942664
    [No Abstract]   [Full Text] [Related]  

  • 6. Using the probability-probability plot and index to augment interpretation of treatment effect for patient-reported outcome measures.
    Cappelleri JC; Bushmakin AG
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):707-13. PubMed ID: 24219046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of the special supplement issue.
    McClellan MB; Newhouse JP
    Health Serv Res; 2000 Dec; 35(5 Pt 2):1061-9. PubMed ID: 11130810
    [No Abstract]   [Full Text] [Related]  

  • 8. Health impact assessment: a tool to help policy makers understand health beyond health care.
    Cole BL; Fielding JE
    Annu Rev Public Health; 2007; 28():393-412. PubMed ID: 17173539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arthroscopic surgery for osteoarthritis of the knee.
    Chambers KG; Schulzer M
    N Engl J Med; 2002 Nov; 347(21):1717-9; author reply 1717-9. PubMed ID: 12448431
    [No Abstract]   [Full Text] [Related]  

  • 10. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy.
    Tunis SR; Stryer DB; Clancy CM
    JAMA; 2003 Sep; 290(12):1624-32. PubMed ID: 14506122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making sense of quality-of-life data.
    Guyatt GH
    Med Care; 2000 Sep; 38(9 Suppl):II175-9. PubMed ID: 10982104
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.
    Ahmed S; Berzon RA; Revicki DA; Lenderking WR; Moinpour CM; Basch E; Reeve BB; Wu AW;
    Med Care; 2012 Dec; 50(12):1060-70. PubMed ID: 22922434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the consensus development conference method in healthcare research.
    Halcomb E; Davidson P; Hardaker L
    Nurse Res; 2008; 16(1):56-71. PubMed ID: 19025106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological issues in treatment effectiveness and outcomes research.
    Mark BA; Salyer J
    Outcomes Manag Nurs Pract; 1999; 3(1):12-8; quiz 18-9. PubMed ID: 9934193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the limitations of statistical analysis of treatment outcomes used in periodontal research.
    Galgut PN
    J Int Acad Periodontol; 2003 Oct; 5(4):92-7. PubMed ID: 14604057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to do (or not to do) ... Assessing the impact of a policy change with routine longitudinal data.
    Lagarde M
    Health Policy Plan; 2012 Jan; 27(1):76-83. PubMed ID: 21278077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding clinical trial outcomes: design, analysis, and interpretation.
    Jacobe HT; Leitenberger JJ; Bergstresser PR
    Dermatol Ther; 2007; 20(2):77-85. PubMed ID: 17537135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What outcomes should US policy makers compare in comparative effectiveness research?
    Bridges JF; Buttorff C
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):217-20. PubMed ID: 20545584
    [No Abstract]   [Full Text] [Related]  

  • 19. Realizing the benefits of practical clinical trials.
    Ofman JJ; Lubeck DP
    JAMA; 2004 Jan; 291(4):425-6; author reply 426. PubMed ID: 14747498
    [No Abstract]   [Full Text] [Related]  

  • 20. The delayed-start study in Parkinson disease: can't satisfy everyone.
    Olanow CW; Rascol O
    Neurology; 2010 Apr; 74(14):1149-50. PubMed ID: 20368635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.